NEW YORK, March 11, 2016 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Central District of California on behalf of investors who purchased Natural Health Trends Corp. (NASDAQ:NHTC) securities between March 6, 2015 and January 12, 2016.
Click here to learn about the case: http://docs.wongesq.com/NHTC-Info-Request-Form-1064. There is no cost or obligation to you.
The complaint alleges that throughout the Class Period Defendants issued false and misleading statements to investors and/or failed to disclose that: (1) the operations of Natural Health Trends’ Chinese entity is not in compliance with applicable Chinese laws; and (2) as a result, Defendants’ statements about Natural Health Trends’ business, operations, and prospects, were false and misleading and/or lacked a reasonable basis at all relevant times.
If you suffered a loss in Natural Health Trends Corp. you have until March 14, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://docs.wongesq.com/NHTC-Info-Request-Form-1064.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: [email protected]


Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 



